Your browser is no longer supported. Please, upgrade your browser.
Settings
AMRN Amarin Corporation plc daily Stock Chart
AMRN [NASD]
Amarin Corporation plc
Index- P/E- EPS (ttm)-0.43 Insider Own0.30% Shs Outstand262.30M Perf Week-2.40%
Market Cap855.10M Forward P/E- EPS next Y-0.23 Insider Trans0.00% Shs Float149.51M Perf Month18.55%
Income-80.80M PEG- EPS next Q-0.07 Inst Own42.20% Short Float3.53% Perf Quarter9.03%
Sales118.00M P/S7.25 EPS this Y-154.30% Inst Trans165.10% Short Ratio1.71 Perf Half Y41.13%
Book/sh-0.04 P/B- EPS next Y41.00% ROA-48.50% Target Price6.30 Perf Year63.00%
Cash/sh0.45 P/C7.27 EPS next 5Y- ROE60.70% 52W Range1.24 - 3.65 Perf YTD72.49%
Dividend- P/FCF- EPS past 5Y19.80% ROI-96.20% 52W High-11.41% Beta0.92
Dividend %- Quick Ratio1.90 Sales past 5Y- Gross Margin72.40% 52W Low160.77% ATR0.18
Employees210 Current Ratio2.10 Sales Q/Q52.10% Oper. Margin-59.50% RSI (14)49.70 Volatility4.46% 5.07%
OptionableYes Debt/Eq- EPS Q/Q57.20% Profit Margin-68.50% Rel Volume0.21 Prev Close3.26
ShortableYes LT Debt/Eq- EarningsNov 03 BMO Payout- Avg Volume3.08M Price3.23
Recom1.60 SMA20-1.00% SMA501.40% SMA20033.78% Volume308,850 Change-0.81%
Oct-19-16Initiated Citigroup Buy $5
Oct-05-16Initiated Cantor Fitzgerald Buy $6
May-12-16Resumed Jefferies Buy
Mar-12-15Upgrade H.C. Wainwright Neutral → Buy $2.50 → $10
Apr-01-14Reiterated MKM Partners Neutral $1.50 → $2
Feb-24-14Reiterated MKM Partners Neutral $2.50 → $1.75
Jan-16-14Downgrade MKM Partners Buy → Neutral $2.50
Nov-08-13Reiterated MKM Partners Buy $5 → $2.50
Oct-30-13Initiated FBR Capital Mkt Perform $2
Oct-17-13Reiterated MKM Partners Buy $9 → $5
Oct-17-13Downgrade Canaccord Genuity Buy → Hold $10 → $3
Oct-17-13Downgrade Aegis Capital Buy → Hold
Mar-20-13Initiated Chardan Capital Markets Hold $8.50
Dec-10-12Reiterated Aegis Capital Buy $25 → $35
Dec-07-12Reiterated Aegis Capital Buy $25 → $35
Jul-12-11Initiated MKM Partners Buy $23
Apr-25-11Reiterated Wedbush Outperform $12 → $18
Apr-18-11Reiterated Canaccord Genuity Buy $11 → $18
Dec-29-10Reiterated Wedbush Outperform $7 → $10
Jul-20-10Initiated Wedbush Outperform $5
Dec-05-16 11:24AM  Why Amarin (AMRN) Could Beat Earnings Estimates Again
Dec-02-16 08:37AM  Amarin (AMRN): Strong Industry, Solid Earnings Estimate Revisions
Nov-29-16 03:03PM  ETFs with exposure to Amarin Corp. Plc : November 29, 2016
Nov-24-16 05:48PM  The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3 at Insider Monkey
Nov-20-16 07:26AM  Penny Stocks: 2 to Buy, 2 to Avoid at Motley Fool
Nov-18-16 09:55AM  Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016
Nov-17-16 09:25AM  Patterson Companies (PDCO) Q2 Earnings: What's in Store?
09:14AM  Can Veeva Systems (VEEV) Pull a Surprise in Q3 Earnings?
Nov-14-16 07:30PM  Pure EPA Vascepa® (icosapent ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Parameters in Statin-Treated Women with Persistent High Triglycerides GlobeNewswire
Nov-11-16 10:27AM  Amarin to Present at the Jefferies 2016 London Healthcare Conference GlobeNewswire
Nov-09-16 01:04PM  AMARIN CORP PLC\UK Financials +6.51%
08:52AM  Amarin's Stock Buckled in October. Is It Now a Bargain? at Motley Fool
Nov-03-16 11:11AM  3 Important Things You Need to Know About Amarin's Q3 Results at Motley Fool -11.29%
07:07AM  Q3 2016 Amarin Corporation PLC Earnings Release - Before Market Open
06:11AM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
05:36AM  Amarin reports 3Q loss
05:30AM  Amarin Reports Third Quarter 2016 Financial Results and Provides Update on Operations GlobeNewswire
Nov-02-16 04:05PM  Investor Calendar Invites You to the Amarin Third Quarter 2016 Earnings Conference Call and Webcast Live on Thursday, November 3, 2016 Accesswire
Oct-27-16 04:56PM  Amarin to Report Third Quarter 2016 Results and Host Conference Call on November 3, 2016 GlobeNewswire
Oct-26-16 10:24AM  Amarin Corporation PLC (ADR) (AMRN) Renders Smaller Vascepa Capsule at Insider Monkey
Oct-25-16 07:00AM  Pure EPA Vascepa® Now Available in New, Smaller Half-Gram Capsule Size GlobeNewswire
Oct-23-16 09:05AM  10 Analyst Stocks Under $10 With Massive Upside Projections at 24/7 Wall St.
Oct-19-16 09:56AM  AstraZeneca's Hyperkalemia Drug NDA Resubmission Accepted
06:37AM  Coverage initiated on Amarin by Citigroup
Oct-18-16 09:23AM  Teva Trisenox Wins CHMP Nod for Expanded Use in Leukemia
Oct-17-16 10:00AM  Tetraphase Begins Phase III Dosing of Antibiotic Candidate
08:57AM  Allergan's Belkyra Gets Swedish Approval for Double Chin
Oct-14-16 10:03AM  Sunesis Submits Response to Questions on Leukemia Drug
09:59AM  OncoGenex Cancer Drug Fails in Phase III Study, Stock Down
Oct-13-16 02:30PM  Allergan Gets Priority Review for Avycaz Label Expansion
02:25PM  Supernus (SUPN) Reports Encouraging Data from ADHD Study
09:59AM  AMAG Issues Encouraging Updates on Makena & Feraheme
Oct-01-16 11:07AM  5 Small-Cap Stocks to Buy in October at Motley Fool
Sep-29-16 09:30AM  Will Amarin (AMRN) Continue to Surge Higher?
Sep-27-16 08:00AM  Amarin Corporation (AMRN) Looks Good: Stock Adds 6.1% in Session
Sep-24-16 09:09AM  Biotech Stocks Under $5: 2 to Buy, 1 to Avoid at Motley Fool
Sep-23-16 04:46PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events +8.89%
Sep-14-16 04:16PM  AMARIN CORP PLC\UK Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events, Financial Statements and
Sep-12-16 06:31PM  Why Polaris Industries, Amarin, and VimpelCom Slumped Today at Motley Fool -6.94%
02:47PM  Raptor Pharmaceutical, Colgate-Palmolive Company & Others: Heres Why These Stocks Are Trending Today at Insider Monkey
05:00AM  Amarins REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee GlobeNewswire
Sep-07-16 04:36PM  Forget Gilead Sciences Inc.: These 3 Stocks Are Better Buys at Motley Fool
09:30AM  Zacks.com featured highlights: Amarin, Compugen, Raptor Pharmaceuticals, ArcelorMittal and Hovnanian Enterprises
07:30AM  Amarin to Present at the Rodman & Renshaw 18th Annual Global Investment Conference GlobeNewswire
Sep-06-16 04:16PM  Explosive Stocks Under $10
Sep-02-16 07:40AM  8 Major FDA Decisions and Trial Results to Watch for in September at 24/7 Wall St.
Sep-01-16 10:20AM  Amarin (AMRN) Ends Patient Randomization in Vascepa Study
Aug-31-16 10:11AM  Is Amarin Corporation Stock a Solid Choice Right Now?
07:30AM  Amarin Randomizes Final Patient into REDUCE-IT Cardiovascular Outcomes Study of Vascepa GlobeNewswire
Aug-29-16 10:59AM  ETFs with exposure to Amarin Corp. Plc : August 29, 2016
Aug-26-16 04:37PM  AMARIN CORP PLC\UK Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and Exhibits
04:20PM  Amarin Announces Mandatory Exchange of Exchangeable Senior Notes Issued in May 2014 and November 2015 GlobeNewswire
Aug-16-16 11:59AM  ETFs with exposure to Amarin Corp. Plc : August 16, 2016
Aug-15-16 01:20PM  Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016
07:38AM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:30AM  Amarin Announces Underwriters Exercise of Option to Purchase Additional American Depositary Shares GlobeNewswire
Aug-12-16 04:12PM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements
Aug-11-16 04:57PM  Why Shake Shack, Amarin, and Valeant Pharmaceuticals Slumped Today at Motley Fool -7.53%
02:50PM  A Look Into Latest Developments Surrounding Yahoo!, Kura Oncology, Kohls and Other Stocks at Insider Monkey
10:34AM  Amarin (AMRN) Stock Drops After Pricing Public Offering
09:20AM  Amarin Prices Public Offering of American Depositary Shares GlobeNewswire
08:08AM  Early movers: KSS, BABA, SHAK, GOOGL, VRX, AMZN, WMT & more at CNBC
Aug-10-16 04:10PM  Amarin Announces Proposed Public Offering of American Depositary Shares GlobeNewswire
Aug-04-16 09:56AM  Thursday Morning's Top Earnings Reports
08:27AM  Amarin reports 2Q loss
07:07AM  Q2 2016 Amarin Corporation PLC Earnings Release - Before Market Open
06:55AM  Amarin Reports Second Quarter 2016 Financial Results and Provides Update on Operations Marketwired
06:13AM  AMARIN CORP PLC\UK Files SEC form 10-Q, Quarterly Report
06:09AM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Stateme
05:45AM  Amarin and FDA Reaffirm Concurrence on REDUCE-IT Through Special Protocol Assessment Agreement Amendment Marketwired
Aug-03-16 04:05PM  Investor Calendar Invites You to the Amarin Second Quarter 2016 Earnings Conference Call and Webcast Live on Thursday, August 4, 2016 Accesswire
Jul-28-16 07:00AM  Amarin to Report Second Quarter 2016 Results and Host Conference Call at 7:30 A.M. ET on August 4, 2016 Marketwired
Jul-20-16 12:09PM  ETFs with exposure to Amarin Corp. Plc : July 20, 2016
Jul-15-16 09:05AM  Coverage Initiated on Select Drug Manufacturer Stocks
Jul-14-16 04:08PM  AMARIN CORP PLC\UK Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jul-12-16 04:25PM  3 Risky Biotech Stocks That Could Make You Rich at Motley Fool
Jul-06-16 08:00AM  Amarin to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference Marketwired
Jul-01-16 05:50PM  ETFs with exposure to Amarin Corp. Plc : July 1, 2016
Jun-30-16 04:07PM  AMARIN CORP PLC\UK Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements
07:30AM  Amarin Appoints Michael W. Kalb Chief Financial Officer Marketwired
Jun-27-16 01:03PM  This Tiny Biopharma Has Been Bucking The Downtrend at Motley Fool
Jun-14-16 09:07AM  Featured Research Report on Drug Manufacturers Stocks
Jun-11-16 11:00AM  Vascepa(R) (Icosapent Ethyl) Showed Significant Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Patients With Type 2 Diabetes and Persistent High Triglycerides Marketwired
Jun-08-16 06:32AM  AMARIN CORP PLC\UK Files SEC form 8-K, Regulation FD Disclosure
Jun-06-16 07:30AM  Vascepa(R) (Icosapent Ethyl) Data to Be Presented at American Diabetes Association's 76th Scientific Sessions Marketwired
Jun-03-16 08:40AM  Amarin (AMRN) Looks Good: Stock Adds 6.7% in Session
Jun-01-16 08:00AM  Amarin to Present at the Jefferies 2016 Global Healthcare Conference Marketwired
06:13AM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events
May-31-16 05:34PM  Why Amarin, Marketo, and Westar Energy Jumped Today at Motley Fool +11.83%
01:30PM  Amarin Announces FDA New Chemical Entity Market Exclusivity Determination for Vascepa(R) (icosapent ethyl) Capsules Marketwired
May-30-16 08:39AM  2 Biotech Stocks Under $5 With Jaw-Dropping Growth Potential at Motley Fool
May-26-16 11:12AM  Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016
May-23-16 08:05AM  10 Speculative Biotech and Biohealth Stocks With Massive Analyst Upside Calls at 24/7 Wall St. +5.81%
May-20-16 10:50AM  Vascepa(R) (Icosapent Ethyl) Showed Significant Reductions in Key Lipid Parameters in Subgroup of Women With Very High Triglyceride Levels Marketwired
May-11-16 07:30AM  Vascepa(R) (icosapent ethyl) and Eicosapentaenoic Acid (EPA) Data to Be Presented at National Lipid Association 2016 Scientific Sessions Marketwired
May-09-16 03:43PM  Here's Why Amarin Corporation's Stock Rallied in April at Motley Fool +7.24%
May-05-16 07:07AM  Q1 2016 Amarin Corporation PLC Earnings Release - Before Market Open -8.33%
07:02AM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
07:00AM  Amarin Reports First Quarter 2016 Financial Results and Provides Update on Operations Marketwired
May-04-16 04:05PM  Investor Calendar Invites You to the Amarin First Quarter 2016 Earnings Conference Call and Webcast Live on Thursday, May 5, 2016 Accesswire -5.26%
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product includes Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.